Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W, Casanova J L, Leupold W, Gahr M, Rösen-Wolff A
Klinik und Poliklinik für Kinderheilkunde der Technischen Universität Dresden, Germany.
Exp Hematol. 1999 Sep;27(9):1368-74. doi: 10.1016/s0301-472x(99)00077-6.
We describe the history of a girl with interferon-gamma-receptor (IFNgammaR1) deficiency and studies performed to identify the molecular and clinical characteristics of this recently discovered disorder. This is the first report of a child from Northern Europe with IFNgammaR1 deficiency. The patient, now 7 years old, first presented with swelling and reddening at the Bacille Calmette-Guerin (BCG) vaccination site, swelling of lymph nodes, hepatomegaly, and an unusually severe varicella rash at the age of 4 months. At that time, she was diagnosed with BCG histiocytosis without typical granuloma formation and was treated with antituberculous agents. During the clinical course of her illness, several different types of atypical mycobacteria and (for the first time in an IFNgammaR1-deficient patient) Listeria monocytogenes were detected. Flow cytometric analysis showed that the patient's monocytes could not bind a monoclonal antibody specific for the IFNgamma-receptor. Our analysis of mRNA derived from the alpha-chain (IFNgammaR1) gene of this receptor revealed deletions of 173 bp and 4 bp in cDNA sequences originating from individual alleles. The 173 bp deletion was located between nucleotide positions 200 and 372, exactly matching those of exon 3, and the 4 bp deletion was located between nucleotide positions 561 and 564 of the coding region of the cDNA. Analysis of genomic DNA revealed the presence of a G to T transition at the 5'end of the splice consensus sequence of intron 3, which explains the absence of exon 3. The other allele carried the 4-base-pair deletion (ACTC) at nucleotide positions 15-18 of exon 5. Twelve months after an allo\geneic bone marrow transplantation, the patient had clinically improved.
我们描述了一名患有γ-干扰素受体(IFNγR1)缺陷女孩的病史,并进行了相关研究以确定这种最近发现的疾病的分子和临床特征。这是北欧首例关于IFNγR1缺陷儿童的报告。该患者现年7岁,4个月大时首次出现卡介苗(BCG)接种部位肿胀、发红,淋巴结肿大,肝肿大以及异常严重的水痘皮疹。当时,她被诊断为无典型肉芽肿形成的卡介苗组织细胞增多症,并接受了抗结核药物治疗。在其疾病临床过程中,检测到几种不同类型的非典型分枝杆菌以及(在IFNγR1缺陷患者中首次发现)单核细胞增生李斯特菌。流式细胞术分析表明,患者的单核细胞无法结合针对γ-干扰素受体的单克隆抗体。我们对该受体α链(IFNγR1)基因衍生的mRNA分析显示源自单个等位基因的cDNA序列中存在173 bp和4 bp缺失。173 bp缺失位于核苷酸位置200至372之间,与外显子3的位置完全匹配,4 bp缺失位于cDNA编码区核苷酸位置561至564之间。对基因组DNA的分析显示,内含子3剪接共有序列的5'端存在G到T的转换,这解释了外显子3的缺失。另一个等位基因在第5外显子的核苷酸位置15 - 18处携带4个碱基对缺失(ACTC)。同种异体骨髓移植12个月后,患者临床症状有所改善。